Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2011
The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastoma
J Stutterheim, L Zappeij-Kannegieter, R Versteeg, et al.
Seminars in Cancer Biology
|
February 1, 1991
Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA class I expression?
P I Schrier, R Versteeg, L T Peltenburg, et al.
Genomics
|
February 13, 2001
The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32
N Spieker, P van Sluis, M Beitsma, et al.
Oncogene
|
March 16, 1995
Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers
G Laureys, F Speleman, R Versteeg, et al.
American Journal of Human Genetics
|
August 1, 1994
Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity
H Caron, P van Sluis, N van Roy, et al.
Genes, Chromosomes & Cancer
|
September 1, 1995
Balanced translocation in a neuroblastoma patient disrupts a cluster of small nuclear RNA U1 and tRNA genes in chromosomal band 1p36
P van der Drift, A Chan, G Laureys, et al.
Leukemia
|
March 13, 2013
The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis
K A Kocemba, H van Andel, A de Haan-Kramer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes
N Van Roy, G Laureys, M Van Gele, et al.
The New England Journal of Medicine
|
January 25, 1996
Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
H Caron, P van Sluis, J de Kraker, et al.
Cytogenetics and Cell Genetics
|
November 27, 1999
Refined physical mapping and genomic structure of the EXTL1 gene
W Wuyts, N Spieker, N Van Roy, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
European Journal of Cancer (Oxford, England : 1990)
|
March 25, 2011
The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastoma
J Stutterheim, L Zappeij-Kannegieter, R Versteeg, et al.
Seminars in Cancer Biology
|
February 1, 1991
Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA class I expression?
P I Schrier, R Versteeg, L T Peltenburg, et al.
Genomics
|
February 13, 2001
The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32
N Spieker, P van Sluis, M Beitsma, et al.
Oncogene
|
March 16, 1995
Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers
G Laureys, F Speleman, R Versteeg, et al.
American Journal of Human Genetics
|
August 1, 1994
Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity
H Caron, P van Sluis, N van Roy, et al.
Genes, Chromosomes & Cancer
|
September 1, 1995
Balanced translocation in a neuroblastoma patient disrupts a cluster of small nuclear RNA U1 and tRNA genes in chromosomal band 1p36
P van der Drift, A Chan, G Laureys, et al.
Leukemia
|
March 13, 2013
The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis
K A Kocemba, H van Andel, A de Haan-Kramer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 1998
Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes
N Van Roy, G Laureys, M Van Gele, et al.
The New England Journal of Medicine
|
January 25, 1996
Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
H Caron, P van Sluis, J de Kraker, et al.
Cytogenetics and Cell Genetics
|
November 27, 1999
Refined physical mapping and genomic structure of the EXTL1 gene
W Wuyts, N Spieker, N Van Roy, et al.
Page
of 6